Plain-English translation of NCT06148935 on ClinicalTrials.gov ↗ ·
This is a real-world study of Vericiguat, a medication prescribed by doctors to help people with a type of heart failure where the heart doesn't pump blood effectively. Researchers in Korea will collect information from routine medical visits and records to learn more about how safe this medication is and how well it works for patients like you.
Vericiguat has already been approved and doctors are prescribing it, but doctors and the Korean health authorities want to gather information about how this medication performs in everyday practice, outside of controlled research settings.
You likely qualify if…
You likely don't qualify if…
You will continue taking your prescribed medication and visiting your regular doctor as you normally would. Researchers will collect information from your medical records and routine visits for up to 12 months, tracking any side effects, hospital stays, and how well the treatment is working. You won't need to do anything different from your normal heart failure care—this study simply gathers real-world data from your existing medical appointments.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
South Korea